November 4, 2019 | Duke Engineering News
A Q&A with Charles Gersbach
October 14, 2019 | GCB News
DARPA recently awarded a grant to a Duke team for a multifaceted research effort aimed at temporarily regulating gene expression using RNA-based techniques that could help protect against pandemic flu by boosting lung resistance to the virus, attacking the virus directly, [...]
October 1, 2019 | Duke Engineering News
September 25, 2019
The new approach highlights the potential for nearly 90% of natural CRISPR-Cas systems for use in human cells
April 16, 2019 | Duke Engineering News
Added piece of RNA could improve the precision of CRISPR 50-fold
February 26, 2019 | NIH Director's Blog
The Gersbach lab's latest work on gene editing for Duchenne Muscular Dystrophy was highlighted in the NIH Director's Blog.
February 18, 2019 | Duke Engineering News
Genetic edits and protein restoration in mouse models of Duchenne muscular dystrophy remain viable one year after single CRISPR treatment
January 1, 2019 | The Scientist
Using CRISPR and other tools, the Gersbach lab and other researchers are modifying DNA methylation, histone marks, and other modifiers of gene expression to understand how they affect health and disease.
November 18, 2018 | Duke Today
Undergraduate Researcher in the Gersbach lab, Ariel Kantor, is one of three Duke seniors to earn a Rhodes Scholarship.
October 19, 2018 | Duke Medicine
Duke researchers are taking their discoveries from the research lab into the marketplace
September 26, 2018 | Duke Today
New NSF grant links four Duke engineers to explore how mechanical changes to genetic material affects gene expression, cancer development.
April 27, 2018 | Duke Today
Biomedical engineers at Duke University have used a CRISPR/Cas9 genetic engineering technique to turn off a gene that regulates cholesterol levels in adult mice, leading to reduced blood cholesterol levels and gene repression lasting for six months after a single treatment.
June 15, 2017
March 15, 2017 | CNBC